Pin I, Grenet D, Scheid P, Domblides P, Stern M, Hubert D
Service de Pneumologie, CHU, Grenoble.
Rev Mal Respir. 2000 Aug;17(3 Pt 2):758-78.
Respiratory impairment is present in almost all adult cystic fibrosis patients and makes the prognosis. Viscous, infected and abundant secretions, inflammation and bronchial oedema, bronchoconstriction and respiratory muscle fatigue lead to airway obstruction, bronchiectasis and respiratory failure. The disease is preferentially located in the upper lobes. Exacerbations of the disease are due to bronchial infections and are often responsible for drops of the respiratory function. Regular spirometric surveillance is fundamental for the prognosis and the assessment of the effects of the treatment. Among adult patients chronic colonisation with mucoid and often multiresistant strains of Pseudomonas Aeruginosa are common. It is treated with i.v. high doses antibiotic courses and nebulized antibiotics between i.v. courses. Respiratory failure may require long term oxygen and non invasive mechanical ventilation. Systemic hypervascularization around the bronchiectasis may lead to moderate to severe hemoptysis, which may require embolization. Pneumothorax are associated with poor prognosis and are treated by pleural drainage and if failure by thoracoscopy.
几乎所有成年囊性纤维化患者都存在呼吸功能损害,这影响预后。黏稠、感染且大量的分泌物、炎症和支气管水肿、支气管收缩以及呼吸肌疲劳会导致气道阻塞、支气管扩张和呼吸衰竭。该病好发于上叶。病情加重是由支气管感染引起的,常导致呼吸功能下降。定期进行肺功能监测对于预后和评估治疗效果至关重要。在成年患者中,黏液样且通常多重耐药的铜绿假单胞菌慢性定植很常见。治疗采用静脉高剂量抗生素疗程,并在静脉疗程之间使用雾化抗生素。呼吸衰竭可能需要长期吸氧和无创机械通气。支气管扩张周围的全身性血管过度增生可能导致中度至重度咯血,这可能需要进行栓塞治疗。气胸与预后不良相关,通过胸腔引流治疗,若治疗失败则采用胸腔镜治疗。